SuperworthEnsysce Biosciences market cap ENSC
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $9.2M
- Highest close in our data
- $261.6M
- Feb 2020
Ensysce Biosciences is worth $9.2M at the close on Oct 23, 2026, at $0.47 a share.
That is up 38% over the last year and down 83% over five years.
Its highest close in our data was $261.6M in Feb 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $9.2M | $1.4M | $10.3M | +135% |
| 2025 | $3.9M | $2.5M | $11.9M | −66% |
| 2024 | $11.6M | $1.5M | $13.1M | +247% |
| 2023 | $3.3M | $1.5M | $6.2M | +57% |
| 2022 | $2.1M | $2M | $96.8M | −98% |
| 2021 | $114M | $20.4M | $124.2M | +46% |
| 2020 | $77.9M | $65.3M | $261.6M | −70% |
| 2019 | $258.5M | $245.5M | $259.3M | +5% |
| 2018 | $245.3M | $238.8M | $245.8M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Ensysce Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| ENSCEnsysce Biosciences | $9.2M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Ensysce Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.